Share this article
BRONX, N.Y., Feb. 18, 2021 /PRNewswire/
Last December, 70-year-old Bronx resident Irma Vega got COVID-19. Like 52 percent of people living in the Bronx, Vega had multiple chronic conditions, meaning her case of COVID-19 could easily become life-threatening. After her positive test, she arrived at Montefiore Medical Center to begin monoclonal antibody treatment.
Dr. Priya Nori, director of the Antibiotic Stewardship Program, an infectious disease specialist at Montefiore Health System, and associate professor of medicine at Albert Einstein College of Medicine
Monoclonal antibodies are created in a lab and function like naturally occurring antibodies, fighting infections before they spread. Studies show that when monoclonal antibodies are given intravenously to high-risk people diagnosed early with COVID-19, it can prevent them from experiencing severe symptoms that lead to hospitalizations.
Share this article
Share this article
ROCKVILLE, Md., Feb. 18, 2021 /PRNewswire/ The National Foundation for Cancer Research (NFCR) announced today that the 2021 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to Tak W. Mak, Ph.D., senior scientist at the Princess Margaret Cancer Centre and university professor at the University of Toronto, and Mark M. Davis, Ph.D., professor of microbiology and immunology at the Stanford University School of Medicine, for their breakthrough discoveries of the structure of T-cell receptor (TCR) and pioneering research in deciphering the mechanisms of T-cell recognition and development. These discoveries have formed a critical part of contemporary immuno-oncology and the molecular foundation for life-saving CAR (chimeric antigen receptor) T-cell therapies, a novel T-cell-based immunotherapy approach already approved by the U.S. Food and Drug Administration (FDA) for the treatment of several types of blood cancer.
Share this article
Share this article
BOSTON, Feb. 18, 2021 /PRNewswire/ Life Biosciences, a pioneering life sciences company targeting the biology of aging, has in-licensed intellectual property related to scientific findings recently described in two publications in the journal
Nature. The publications, based on research conducted in animal models, report that therapies targeting the biology of aging have the potential to not only slow the progression but also to reverse aging-related disease. Life Biosciences intends to develop new therapies for aging-related conditions. These two studies open a new frontier in biotechnology and medicine, says Mehmood Khan, MD, Chief Executive Officer of Life Biosciences. They pave the way for the development of groundbreaking treatments to restore the function of aging organ systems and thereby allow people to live healthier longer.
Content warning: Anti-Black racism and discrimination
Black people have long been barred from academia and entrepreneurship opportunities due to institutionalized racism and prejudice. In honour of Black History Month,
The McGill
Tribune highlights notable scientists and inventors who succeeded in making important scientific progress in spite of systemic anti-Black racism.
Madam C.J. Walker (1867-1919)
Walker was one of many Black women afflicted with scalp ailments in the early 20th century. Exposure to harsh lye soap and sulphur, commonplace at the time among laundresses like Walker, contributed to severe hair loss. In 1904, she started working as a sales agent with Annie Turbo Malone, a Black chemist and entrepreneur who designed hair products specifically for Black women. With the help of her four barber brothers, Walker developed a scalp conditioning and healing formula by experimenting with both store-bought and homemade products. She used this to launch her own busine